These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 26755333)

  • 1. Genome-editing Technologies for Gene and Cell Therapy.
    Maeder ML; Gersbach CA
    Mol Ther; 2016 Mar; 24(3):430-46. PubMed ID: 26755333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing and CRISPR in the clinic: current and future perspectives.
    Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Delivery Vehicles for Genome Editing.
    Nelson CE; Gersbach CA
    Annu Rev Chem Biomol Eng; 2016 Jun; 7():637-62. PubMed ID: 27146557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics.
    Krittanawong C; Sun T; Herzog E
    Curr Cardiol Rev; 2017; 13(4):301-304. PubMed ID: 28782493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing technologies to fight infectious diseases.
    Trevisan M; Palù G; Barzon L
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Genome Editing as a Therapeutic Approach.
    Ho BX; Loh SJH; Chan WK; Soh BS
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing.
    Liu J; Shui SL
    J Control Release; 2016 Dec; 244(Pt A):83-97. PubMed ID: 27865852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of designer nucleases for targeted gene and genome editing in plants.
    Weeks DP; Spalding MH; Yang B
    Plant Biotechnol J; 2016 Feb; 14(2):483-95. PubMed ID: 26261084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multiplexed CRISPR targeting platforms.
    Cao J; Xiao Q; Yan Q
    Drug Discov Today Technol; 2018 Aug; 28():53-61. PubMed ID: 30205881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene editing and its application for hematological diseases.
    Osborn MJ; Belanto JJ; Tolar J; Voytas DF
    Int J Hematol; 2016 Jul; 104(1):18-28. PubMed ID: 27233509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
    Batzir NA; Tovin A; Hendel A
    Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome engineering: a new approach to gene therapy for neuromuscular disorders.
    Nelson CE; Robinson-Hamm JN; Gersbach CA
    Nat Rev Neurol; 2017 Nov; 13(11):647-661. PubMed ID: 28960187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered Viruses as Genome Editing Devices.
    Chen X; Gonçalves MA
    Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects.
    Singh K; Bhushan B; Kumar S; Singh S; Macadangdang RR; Pandey E; Varma AK; Kumar S
    Curr Gene Ther; 2024; 24(5):377-394. PubMed ID: 38258771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.